NCT06980077 - Ivonescimab for the Treatment of Thymic Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 15, 2025

Primary Completion Date

June 17, 2027

Study Completion Date

June 17, 2028

Conditions

Thymus Carcinoma

Interventions

PROCEDURE

Biopsy Procedure

Undergo biopsy

PROCEDURE

Biospecimen Collection

Undergo collection of blood and urine samples

PROCEDURE

Computed Tomography

Undergo CT

BIOLOGICAL

Ivonescimab

Given IV

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

RECRUITING

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles